epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove BC Powder
    aspirin/ caffeine
  • remove Duexis
    ibuprofen/ famotidine
  • remove Latuda
    lurasidone
  • remove Leqembi (lecanemab-irmb)
    lecanemab

multicheck MultiCheck Results - 3 Interactions

Smiley face Smiley face

Avoid/Use Alternative

Smiley face Smiley face BC Powder (aspirin/ caffeine) + Duexis (ibuprofen/ famotidine)

Avoid/Use Alternative


aspirin + ibuprofen

avoid aspirin >325 mg/day; otherwise, use alternative or monitor bleeding s/sx, renal fxn; may give low-dose aspirin at least 2-4h before or at least 8h after single ibuprofen 400 mg dose: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), renal impairment, other adverse effects; ibuprofen may inhibit cardioprotective effect of low-dose aspirin (additive effects, duplicate therapy; possible competition for platelet binding sites)

Monitor/Modify Tx


caffeine + ibuprofen

monitor BP; avoid excessive caffeine intake: combo may incr. risk of HTN (additive effects)

Monitor/Modify Tx

Smiley face Smiley face BC Powder (aspirin/ caffeine) + Leqembi (lecanemab-irmb) (lecanemab)

Monitor/Modify Tx


aspirin + lecanemab

monitor bleeding s/sx: combo may incr. risk of intracerebral bleeding, including life-threatening (additive effects)

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information